Project Grant HT94252310544
Award Date
7/1/23
Completion Date
6/30/26
Dollars Obligated
$410K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Tacoma, WA 98402, USA
Similar Awards
The Geneva Foundation received a $4,676,544 Project Grant award from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420) to develop and validate innate immunome-targeted therapies to create a pro-survival and organ-protective phenotype after hemorrhage at the point of injury. Specifically, the Foundation will investigate immunotherapy approaches for hemorrhage treatments using innate immunome-targeted therapies from July 1, 2023 to...
The Defense Health Agency awarded a $899,999 Project Grant to Wake Forest University Health Sciences under the Military Medical Research and Development program (CFDA 12.420) to develop a novel point-of-care assay for monitoring rejection and immunosuppression in vascularized composite allotransplantation (VCA) recipients. The project aims to transform healthcare for service members and the public through innovative biomedical research focused on medical solutions for the battlefield. The...
The Defense Health Agency awarded a $499,998.00 Project Grant to Brigham & Women's Hospital Inc. to conduct research on "Identifying Biomarkers of Human VCA Rejection to Enable Noninvasive Diagnostic Testing." This grant, funded through the Military Medical Research and Development program (CFDA 12.420), supports biomedical research initiatives aimed at improving health outcomes for military service members, veterans, and the broader public. The research project at Brigham &...
The Department of the Army's Military Medical Research and Development program (CFDA 12.420) awarded a $1,009,750 Project Grant to The Geneva Foundation, a non-profit research organization based in Tacoma, Washington. This 3-year grant, awarded on August 1, 2025, will support advanced biomedical research to characterize the genetic and functional basis of chemoresistance in small cell lung cancer. The research aims to transform healthcare for military service members and the broader public by...
The Johns Hopkins University received a $722,589.00 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to conduct research on localized and inflammation-responsive immunotherapy of vascular composite allograft (VCA) rejection. The 3-year project, which commenced on July 1, 2023 and is slated for completion by June 30, 2026, aims to transform healthcare for service members and the American public by investigating innovative...
The Geneva Foundation was awarded a $1,597,740 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from June 2022 to June 2026 to develop new methods for accessing extracellular vesicle MDM2 DNA cargo as a potential liposarcoma biomarker. Through support of basic, applied, and advanced biomedical research, the Military Medical Research and Development program aims to transform...
The U.S. Department of Defense's Defense Health Agency (DHA) awarded a $750,000 Project Grant to Stanford University to implement a spatial and single-cell multiplexed platform for the development of targeted therapies for vascularized composite allotransplantation. The funding is provided through the Military Medical Research and Development (CFDA 12.420) federal grant program, which supports advanced biomedical research to transform healthcare for military service members and the broader...
The Geneva Foundation received a $453,029 Project Grant award from the Department of the Army Medical Command on February 1, 2021 to improve the therapeutic index of antibody drug conjugates targeting metastatic breast cancer. Funded through January 31, 2024 under the Military Medical Research and Development program (CFDA 12.420), this award will support the Foundation's work to transform healthcare and investigate medical solutions for the battlefield by developing more effective targeted...
The Department of the Army awarded a $6,663,794 Project Grant under the Military Medical Research and Development (CFDA 12.420) program to The Geneva Foundation, a non-profit medical research organization based in Tacoma, Washington. The grant, titled "PRECISIE RTD TRIAL: PRECISION WITH RETURN-TO-DUTY DECISIONS IN THE MILITARY", will fund advanced biomedical research focused on improving return-to-duty decisions for military personnel. The Geneva Foundation will collaborate with a...
This $366,419 Project Grant awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports The Johns Hopkins University's research into "Localized and Inflammation-Responsive Immunotherapy of VCA Rejection." The 3-year award period runs from July 1, 2023 to June 30, 2026. The Johns Hopkins University, a private non-profit research university, will conduct this biomedical research to develop innovative solutions for treating...